Evidence map›Paper›PMID 28275867›Full record

ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2017

Myositis ossificans in children: a review.

N K Sferopoulos, R Kotakidou, A S Petropoulos

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Fibrodysplasia ossificans progressiva.Clinical case reports · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Non-traumatic myositis ossificans.Autopsy & case reports · 2021
    Review
  14. Article
  15. Article
  16. [A case of progressive ossifying myositis caused byZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

N K SferopoulosDepartments of Pediatric Orthopaedics, Pathology and Pediatric Surgery, "G. Gennimatas" Hospital, P. Papageorgiou 3, 546 35, Thessaloniki, Greece. sferopoulos@in.gr.
R KotakidouConsultant Pathologist, Department of Pathology, "G. Gennimatas" Hospital, Thessaloniki, Greece.
A S PetropoulosEmeritus Professor of Pediatric Surgery, Aristotle University of Thessaloniki, "G. Gennimatas" Hospital, Thessaloniki, Greece.
Aristotle University of Thessaloniki · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The formation of lamellar bone in the soft tissues, where bone normally does not exist, is called myositis ossificans. However, it would be more accurate to describe as myositis ossificans the involvement of skeletal muscles and as ectopic or heterotopic ossification the involvement of soft tissues in general. The lesion is subdivided in genetic and non-genetic or acquired types. Myositis or fibrodysplasia ossificans progressiva is a debilitating rare genetic disorder. Clinical suspicion of the disease in the newborn on the basis of malformed great toes may lead to early clinical diagnosis, confirmatory diagnostic genetic testing and avoidance of iatrogenic harmful procedures. Acquired lesions involve the neurogenic myositis ossificans and the non-neurogenic disorder. The latter is defined either as circumscribed myositis ossificans that is post-traumatic or as idiopathic/pseudomalignant myositis ossificans that is non-traumatic and may be a form fruste of fibrodysplasia ossificans progressiva. Ossification in fibrodysplasia ossificans progressiva is irreversible, unlike other forms of heterotopic ossification. In this retrospective study, a total of 22 children with myositis ossificans treated in a 20-year period were identified and classified. Two patients were diagnosed with myositis/fibrodysplasia ossificans progressiva, one with neurogenic myositis ossificans, one with idiopathic/pseudomalignant myositis ossificans and 18 patients with circumscribed myositis ossificans. The clinical features, imaging and histological findings as well as treatment modalities and complications of myositis ossificans in our patients are presented and discussed.

Indexed as

Genetic Predisposition to DiseaseAge FactorsBiopsy, NeedleChildChild, PreschoolCohort StudiesConservative TreatmentDatabases, FactualDisease ProgressionEarly DiagnosisFemaleFollow-Up StudiesHumansImmunohistochemistryInfantInfant, NewbornChildrenEctopic/Heterotopic ossificationFibrodysplasia ossificans progressivaMyositis ossificans

Identifiers

PMID28275867
OpenAlexW2592527854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.